Wenzheng Liu
1095 Jiefang Avenue
Wuhan, 430030, China
Wuhan, 430030, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Development of a multifunctional nucleic acid response platform utilizing the Cas12a and Cas13a integrated targeting system.
Journal: Nucleic acids research
Published: November 20, 2025
PRMT1-mediated asymmetric dimethylation of arginine residue 602 in DDX1 promotes cholangiocarcinoma progression.
Journal: Clinical and molecular hepatology
Published: November 08, 2025
KDM4A-driven SMAD5/TGFβ axis activation as a therapeutic target in cholangiocarcinoma: mechanistic insights and translational implications.
Journal: Cell & bioscience
Published: April 12, 2025
Correction: STUB1-mediated K63-linked ubiquitination of UHRF1 promotes the progression of cholangiocarcinoma by maintaining DNA hypermethylation of PLA2G2A.
Journal: Journal of experimental & clinical cancer research : CR
Published: October 07, 2024
Pathological complete response following neoadjuvant chemotherapy with PD-1 inhibitor for locally advanced pancreatic cancer: case report.
Journal: Journal of gastrointestinal oncology
Published: July 17, 2024
PPM1G Inhibits Epithelial-Mesenchymal Transition in Cholangiocarcinoma by Catalyzing TET1 Dephosphorylation for Destabilization to Impair Its Targeted Demethylation of the CLDN3 Promoter.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 30, 2024
STUB1-mediated K63-linked ubiquitination of UHRF1 promotes the progression of cholangiocarcinoma by maintaining DNA hypermethylation of PLA2G2A.
Journal: Journal of experimental & clinical cancer research : CR
Published: June 03, 2024
MBD2 regulates the progression and chemoresistance of cholangiocarcinoma through interaction with WDR5.
Journal: Journal of experimental & clinical cancer research : CR
Published: May 25, 2024
Upregulation of RSPO3 via targeted promoter DNA demethylation inhibits the progression of cholangiocarcinoma.
Journal: Clinical epigenetics
Published: August 07, 2023
SMAD Proteins in TGF-β Signalling Pathway in Cancer: Regulatory Mechanisms and Clinical Applications.
Journal: Diagnostics (Basel, Switzerland)
Published: July 08, 2023
The emerging roles of CEACAM6 in human cancer (Review).
Journal: International journal of oncology
Published: June 14, 2023
Targeting polycomb repressor complex 2-mediated bivalent promoter epigenetic silencing of secreted frizzled-related protein 1 inhibits cholangiocarcinoma progression.
Journal: Clinical and translational medicine
Published: June 14, 2023
Last Updated: 09/26/2026